AstraZeneca Aktie
154,45
EUR
-0,40
EUR
-0,26
%
135,92
GBP
+0,78
GBP
+0,58
%
Werbung
AstraZeneca Aktie Analyse
| 03.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 12.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 10.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 29.08.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 21.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 17.08.12 | AstraZeneca underperform | Credit Suisse Group | |
| 06.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 02.08.12 | AstraZeneca reduce | Nomura | |
|
Werbung
|
|||
| 27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 21.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 15.06.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 05.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 04.05.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 27.04.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 23.04.12 | AstraZeneca reduce | Nomura | |
| 07.02.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 06.02.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 06.02.12 | AstraZeneca underperform | Credit Suisse Group | |
| 01.02.12 | AstraZeneca reduce | Nomura | |
| 21.12.11 | AstraZeneca reduce | Nomura | |
| 13.12.11 | AstraZeneca underperform | Credit Suisse Group | |
| 28.10.11 | AstraZeneca reduce | Nomura | |
| 19.10.11 | AstraZeneca underperform | Credit Suisse Group | |
| 21.07.11 | AstraZeneca reduce | Nomura | |
| 20.07.11 | AstraZeneca reduce | Nomura | |
| 18.07.11 | AstraZeneca reduce | Nomura | |
| 13.07.11 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 12.07.11 | AstraZeneca reduce | Nomura | |
| 28.04.11 | AstraZeneca sell | UniCredit Research | |
| 22.02.11 | AstraZeneca sell | UniCredit Research | |
| 09.11.09 | AstraZeneca underweight | JP Morgan Chase & Co. | |
| 23.10.09 | AstraZeneca underperform | Jefferies & Company Inc. | |
| 07.09.09 | AstraZeneca reduce | Nomura | |
| 25.08.09 | AstraZeneca underperform | Credit Suisse Group | |
| 06.08.09 | AstraZeneca underperform | Jefferies & Company Inc. | |
| 14.05.09 | AstraZeneca underperform | Jefferies & Company Inc. | |
| 11.05.09 | AstraZeneca underperform | Credit Suisse Group | |
| 17.03.09 | AstraZeneca underperform | Credit Suisse Group | |
| 20.11.08 | AstraZeneca sell | Goldman Sachs Group Inc. | |
| 11.09.08 | AstraZeneca sell | Goldman Sachs Group Inc. | |
| 07.07.08 | AstraZeneca sell | Jyske Bank Group | |
| 25.04.08 | AstraZeneca underweight | JP Morgan Chase & Co. | |
| 26.03.08 | AstraZeneca underweight | JP Morgan Chase & Co. | |
| 12.03.08 | AstraZeneca underweight | JP Morgan Chase & Co. | |
Werbung
Werbung